Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial
- 1 November 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 378 (9806), 1868-1873
- https://doi.org/10.1016/s0140-6736(11)61522-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialThe Lancet Oncology, 2010
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized SettingJNCI Journal of the National Cancer Institute, 2009
- HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialThe Lancet Oncology, 2009
- How to evaluate emerging technologies in cervical cancer screening?International Journal of Cancer, 2009
- HPV Screening for Cervical Cancer in Rural IndiaThe New England Journal of Medicine, 2009
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialThe Lancet, 2007
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerThe New England Journal of Medicine, 2007
- Chapter 9: Clinical applications of HPV testing: A summary of meta-analysesVaccine, 2006
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006